Search
12 articles for “high-density lipoproteins”
-
Lipid Profile Analysis in Type 2 Diabetes Mellitus Patients Belonging to Kota South
Abstract: Background: Diabetes mellitus is a category of metabolic disorders marked by persistently high blood sugar levels and abnormalities in the metabolism of fats, proteins, and carbohydrates as a result of deficiencies in the secretion or action of insulin, or both. Diabetic dyslipidemia is characterized by elevated low-density lipoprotein cholesterol (LDL-C), reduced high-density lipoprotein cholesterol (HDL-C), and increased triglyceride (TG) levels. The objective of this study is to assess the lipid …
Published in Research and Reviews : A Journal of Immunology · Vol. 13, Issue 2, 2023 · pp. 38–41 Read article
-
Screening of Obesity and its Associated Biochemical Markers in North Indian Population
Abstract: The aim of the present study was to explore out the prevalence of biochemical markers, and their connection with obesity in north Indian population. The sample size was 300, between the ages of 10 and 60 years old from all the ethics of north India. The obesity was calculated by body mass index based on the World Health Organization standard. We collected venous blood for biochemical markers investigation (total cholesterol, …
Published in Research and Reviews: A Journal of Health Professions · Vol. 8, Issue 3, 2018 · pp. 51–54 Read article
-
New Topics in Serum Copeptin Levels in Hypertension: Is There an Interrelation with Inflammatory Biomarkers?
Abstract: This study aimed to test the hypothesis that the link between serum copeptin (Cop) levels and hypertension is related to low grade of inflammation and atherosclerosis indices. This observational cross section study was done in the Department of Biology, College of Science at the University of Al-Mustansiriya in Baghdad, Iraq. A total number of 18 healthy subjects (Group I) and 66 patients (Group II) were enrolled in this study. Patients …
Published in Research and Reviews : A Journal of Immunology · Vol. 6, Issue 2, 2016 · pp. 20–28 Read article
-
Dyslipidaemia and its Association with Fasting versus Non Fasting Lipid Profile Values
Abstract: Lipid profile is a panel of blood tests used as a screening tool for dyslipidaemia. Dyslipidaemia is defined as disturbances of cholesterol and triglyceride levels and recognized as risk factor for cardiovascular diseases. It includes total cholesterol, low density lipoproteins (LDL), high density lipoproteins (HDL), very low density lipoproteins (VLDL) and triglycerides. This study assesses the prevalence of dyslipidaemia among apparently healthy individuals in physically fit defence service personnel and …
Published in Research and Reviews: A Journal of Medicine · Vol. 10, Issue 2, 2020 · pp. 26–31 Read article
-
Does an Association Exist Between Maternal Serum Lipid Parameters and Birth Weight of Newborn? A Cross-Sectional Analysis
Abstract: Pregnant woman undergoes profound hormonal, metabolic changes and adaptions to achieve success in terms of healthy baby as outcome. Lipids are more significantly involved as a source of energy, fat-soluble vitamins, and precursors for various hormones. We decided to study pattern of lipid profile parameters at puerperium phase, as an indicative of lipid status of woman in late pregnancy and its influence on birth weight of newborn.Cross-sectional analysis was carried …
Published in Research and Reviews : A Journal of Medical Science and Technology · Vol. 6, Issue 2, 2017 · pp. 46–51 Read article
-
A Comparative Study of Lipid Profile in Pre-Dialysis and Post-Dialysis End-Stage Renal Disease Patients
Abstract: Background: Chronic kidney disease (CKD) represents a major public health concern in India, with its prevalence increasing at an alarming rate. Individuals with CKD are at a substantially higher risk of developing cardiovascular disease (CVD), which remains the leading cause of mortality in this population. Dyslipidemia is particularly pronounced among patients with end-stage renal disease (ESRD); however, limited data are available regarding the impact of hemodialysis on lipid profile alterations. …
Published in Research and Reviews: A Journal of Medicine · Vol. 16, Issue 1, 2026 · pp. 25–31 Read article
-
Nanorobots: The Fight against Cholesterol
Abstract: Cardiovascular disease (CVD) rests leading reason of death globally, with atherosclerosis, the buildup of plaque in arteries, playing a central role. Current treatment strategies, including lifestyle changes and medications, often fall short in completely reversing or preventing the progression of atherosclerosis. This has spurred the exploration of innovative approaches, with nanorobotics emerging as a promising avenue for targeted plaque control and high-density lipoprotein (HDL) enhancement. This article discusses how nanorobots …
Published in Nano Trends – A Journal of Nano Technology & Its Applications · Vol. 27, Issue 2, 2025 · pp. 23–32 Read article
-
Microalbuminuria as an Independent Screening Tool in Patients with Myocardial Infarction
Abstract: Acute Myocardial Infarction (AMI) is a condition in which there is an inadequate supply of blood and oxygen to a portion of myocardium; most common cause being atherosclerosis of coronary vessels. Microalbuminuria (MAU) is defined as urinary albumin-to-creatinine ratio (UACR) of 30–300 mg/g. It is considered as marker of generalized endothelial dysfunction and vasculopathy and suggested to contribute to the formation of atherosclerotic lesion and ultimately leading to risk of …
Published in Research and Reviews : A Journal of Medical Science and Technology · Vol. 6, Issue 2, 2017 · pp. 41–45 Read article
-
Health Status of Adolescents in Rural Area of Anand
Abstract: Aim: The study was carried out with the aim to access the health status of adolescents in a rural area of Anand. So far no studies were done over the rural areas of Anand District. Method: Cross-sectional study was conducted on 417 students of 13 – 15 years (283 males and 134 females). The data were collected using a semi-structured questionnaire for socio-demographic, anthropometry (Height, Weight, BMI), physical activity level. …
Published in Research and Reviews: A Journal of Health Professions · Vol. 8, Issue 3, 2018 · pp. 91s–96s Read article
-
Understanding Metabolic Syndrome and its Nutritional Management
Abstract: Metabolic syndrome (MetS) is a collection of risk factors, especially when at least three occur together, including abdominal obesity, dyslipidemia, low high-density lipoprotein cholesterol (HDL-c) levels, hypertension, and insulin resistance. MetS is linked to an increased risk of diabetes and cardiovascular diseases (CVDs) if treatment is not received.The causes of MetS include both genetic and acquired factors that contribute to issues such as insulin resistance, chronic low-grade inflammation, and obesity. …
Published in International Journal of Sustainability · Vol. 2, Issue 1, 2025 · pp. 26–37 Read article
-
A Systematic Review on Coronary Heart Disease: A Transient Ischemic Stroke
Abstract: Coronary Heart Disease (CHD) and Transient Ischemic Attack (TIA) are significant cardiovascular and cerebrovascular disorders that often share similar risk factors and underlying pathophysiological processes. CHD involves the narrowing or obstruction of the coronary arteries due to atherosclerosis, resulting in diminished blood flow to the heart. A transient ischemic attack (TIA), often called a "mini stroke," occurs when blood flow to the brain is briefly disrupted, usually due to a …
Published in Research and Reviews : Journal of Surgery · Vol. 14, Issue 3, 2025 Read article
-
Review of Atorvastatin As A Potent Drug For Cardio-Vascular Disease(CVD)
Abstract: Cardiovascular disease (CVD), particularly atherosclerosis, remains the leading cause of death worldwide, significantly burdening public health, especially in Western societies. Metabolic syndrome and arrhythmic complications further exacerbate cardiovascular morbidity and mortality. Among restorative specialists, statins particularly atorvastatin have gotten to central in both the essential and auxiliary anticipation of coronary heart infection (CHD) due to their strong lipid-lowering properties and additional pleiotropic impacts. Atorvastatin, a selective HMG-CoA reductase inhibitor, not …
Published in Research & Reviews: A Journal of Drug Design & Discovery · Vol. 12, Issue 3, 2025 · pp. 8–18 Read article